Acomplia’s main ingredient is Rimonabant, which is a CB1 cannabinoid receptor antagonist, which is a complicated way of saying that it can provide users with a reduction in appetite. This is the first “CB1 cannabinoid receptor antagonist” to be approved anywhere in the world to treat obesity. However, its use is contingent upon the inclusion of a healthy diet and exercise into the lifestyle of users.

Many view Rimonabant and by extension Acomplia to be the new “wonder drug” of weight loss. It has gone through a variety of clinical studies in which patients took this drug for a year, and the results were very good in terms of weight loss, improved insulin sensitivity, and increases in HDL cholesterol. These studies provided the information that precipitated its approval in Europe.

However, many are watching carefully because it is the first of its kind and works very differently than any other obesity drug. It directly affects a part of the brain called the endocannabiniod system, which regulates relaxation, pain tolerance and pleasure. No one knows how directly interfering with the operation of this system will affect users in the long term. The endocannabiniod system protects the brain during any type of brain trauma; some experts have suggested that use of this product may well block the system from doing its job when it is needed during times of trauma.

It is important when taking any prescribed medication to carefully review the materials enclosed in order to be aware of any possible side effects. For instance, the following side effects are associated with use of Acomplia - depression, anxiety and nausea. Also, we discovered that roughly 1 in 8 patients who were taking this medication left the study because of these side effects.

It has come to our attention that Acomplia is available in the US via the internet through various overseas distributors, and we can in no way support getting this medication through this method. This is clearly a medical grade pharmaceutical which must be used under medical supervision, especially since it directly affects brain chemistry.

• May help with true obesity

• Must be medically supervised
• Possible side effects both known and unknown
• Not currently available in US at time of review
• we would like to see more convincing customer testimonials or before & after pictures.

Acomplia is clearly a pharmaceutical drug that is targeted toward those who are chronically and severely obese, and not for those who simply need to lose weight. As mentioned earlier it does have some known side effects such as depression, anxiety and nausea. It also affects the brain in a very new way which may eventually result in some other issues and side effects. It is for this reason we firmly believe that the use of this medication must be medically supervised.

Nevertheless, this medication is not currently approved for use in the, US for a variety of reasons. As mentioned earlier, it is available from over seas distributors; however, we can not recommend nor support the acquisition of this medication through this method.

For those who are not obese and who want to address issues around weight loss there are other holistically based and safe methods available to them. For instance, many consumers have achieved outstanding results with the use of Hoodia, an appetite suppressant, which has been proven to be able to convince the brain that the stomach is full – naturally and safely.